CareLit · DOI-Nachweis · Pneumologie
Safety and Immunogenicity of a novel intradermal influenza vaccine in elderly adults (aged >60 years): randomised controlled phase 3 trial results
DOI 10.1055/s-0029-1213950
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Arnou, G Icardi, M De Decker, A Ambrozaitis, M Kazek, F Weber
ZeitschriftPneumologie
Ausgabe03/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Each year, seasonal trivalent inactivated influenza vaccines (TIV) provide protection for hundreds of millions of individuals worldwide. Yet there is need to improve vaccine efficacy for the elderly. An influenza vaccine (containing 15µg hemagglutinin/strain), using a novel intradermal (ID) microinjection system, has been developed targeting adults older than 60 years. Methods: A multicentre, randomized…
Zitieren
Zitierempfehlung
R Arnou, G Icardi, M De Decker, A Ambrozaitis, M Kazek, F Weber (2009) Safety and Immunogenicity of a novel intradermal influenza vaccine in elderly adults (aged >60 years): randomised controlled phase 3 trial results. Pneumologie (03). https://doi.org/10.1055/s-0029-1213950
Mit CareLit weiterarbeiten